
Who's online
There are currently 8 users and 255 guests online.
Online users
- Inga
- nicoM
- MUTOMBO MULANGU A...
- patrick sampao
- nick golding
- Kabogo
- Moon
- Sysadmin
News Flash
Recent blog posts
- Where the real battle is won
- Amazing statements by leading malariologists
- How was malaria of 100 years ago eradicated in Palestine/Israel? And without vaccine?
- Winston Hide's courageous move
- Event: Symposium Malaria, maternal and infant health
- Job: Senior Lecturer / Lecturer in Epidemiology
- Job: Inspiring scientists in infectious tropical diseases
- Can we maintain effectiveness of the tools?
- Advertising on MalariaWorld
- Malaria elimination country briefings published by the UCSF Global Health Group
Active forum topics
- The role of community education and involvement in malaria control
- Introduce yourself to MalariaWorld members
- Fighting drug resistance by switching to environmental management of mosquito habitats
- Need for additional group to supplement WHO in fight against malaria
- Sustainable additions to WHO and PMI strategy
New forum topics
- Fighting drug resistance by switching to environmental management of mosquito habitats
- Grand Challemges Canada round 2. Help fund a malaria related project!
- Open Access 2.0:How to achieve this
- Pouring gasoline on the insecticide resistance fire?
- Need for additional group to supplement WHO in fight against malaria
The evolution of different members of the Pvrbp2 family and their relatively high degree of polymorphism suggests that the proteins encoded by these genes are important for parasite survival and are under immune selection.
Plasmodium falciparum SURFIN4.2 (PFD1160w) is a polymorphic protein expressed on the surface of parasite-infected erythrocytes. Such molecules are expected to be under strong host immune pressure, thus we analyzed the nucleotide diversity of the N-terminal extracellular region of SURFIN4.2 using P. falciparum isolates obtained from a malaria hypoendemic area of Thailand.
This study indicates that transmission of P. knowlesi is occurring in the Ranong province of Thailand or the Kawthoung district of Myanmar.
Data from the present study put doubt regarding the pfnhe-1 gene as to whether it could be used as the suitable marker for QN resistance in Thailand.
Results indicate difference in the prevalence and distribution of G6PD gene variants among the Thai and Burmese populations in different malaria endemic areas.
Thus, we evaluated the influence of pfcrt and pfmdr1 polymorphisms on in vitro chloroquine sensitivity in 89 adapted isolates of P. falciparum from Thailand. We found that 87 of 89 isolates contained the CVIET haplotype of the pfcrt gene.
To determine the prevalence of P. knowlesi malaria in malaria-endemic areas of Thailand, we analyzed genetic characteristics of P. knowlesi circulating among naturally infected macaques and humans.
Analysis of gene mutation and amplification were performed by nested real-time polymerase chain reaction and SYBR Green I real-time polymerase chain reaction, respectively.
AP, DHP and AL all remained efficacious treatments for the treatment of falciparum malaria in Cambodia-Thailand border area.
Chloroquine (CQ) resistant vivax malaria is spreading. In this case, Plasmodium vivax infections during pregnancy and in the postpartum period were not satisfactorily cleared by CQ, despite adequate drug concentrations.
